England Confirms Fifth Mpox Case

A new instance of the mpox strain circulating in parts of central and east Africa has been identified in Leeds. The affected individual had recently returned from Uganda, a country where Clade 1b mpox, previously known as monkeypox, has been detected. This marks the fifth person in England to be diagnosed with this illness in recent weeks; the preceding four individuals resided in the same London household and have since recovered. Health authorities indicate that close contacts of the Leeds patient are being traced, but the risk to the broader UK population remains low. The infected person is currently receiving medical attention at a hospital in Sheffield. Mpox symptoms frequently encompass fever, headaches, and fatigue, followed by a painful rash and lesions on the body. While most individuals recover, the condition can be severe for some. Transmission occurs through close contact, including sexual activity, skin-to-skin interaction, and very close talking or breathing near another person. Prof Susan Hopkins, chief medical adviser at the UK Health Security Agency, stated: “It is thanks to clinicians rapidly recognising the symptoms and our diagnostics tests that we have been able to detect this new case.” She further added, “The risk to the UK population remains low following this fifth case, and we are working rapidly to trace close contacts and reduce the risk of any potential spread.” Prof Hopkins mentioned that those identified would be offered testing and vaccination. The UK has experienced cases of a milder form of mpox, known as Clade 2, for several years. Instances of the more serious Clade 1 are less common in the UK. However, UK health officials had anticipated identifying a small number of cases after a new variant of the virus began spreading in the Democratic Republic of Congo over the past year. Clade 1b mpox has disseminated from DR Congo to Burundi, Rwanda, Uganda, and Kenya in recent months. This situation led the World Health Organization to declare an international public health emergency in August, which it confirmed last week is still in effect. Nevertheless, some indications suggest that the surge in mpox infections is diminishing, according to medical professionals at a clinic in eastern DR Congo. Millions of vaccine doses are being dispatched to the most severely affected regions of east and central Africa to aid in controlling the outbreak. Sweden, Germany, India, Thailand, Canada, and the US have all reported imported cases of Clade 1b, but significant onward transmission has not been observed to date.